ARDIZZONI, ANDREA
ARDIZZONI, ANDREA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Docenti di ruolo di Ia fascia
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series
2016 Graziani, Tiziano; Ceci, Francesco; Castellucci, Paolo; Polverari, Giulia; Lima, Giacomo Maria; Lodi, Filippo; Morganti, Alessio Giuseppe; Ardizzoni, Andrea; Schiavina, Riccardo; Fanti, Stefano
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel
2016 Ceci, F; Castellucci, P; Graziani, T; Schiavina, R; Renzi, R; Borghesi, M; Di Tullio, P; Brunocilla, E; Ardizzoni, A; Fanti, S
18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results
2016 G Polverari, V Ambrosini, F Gelsomino, S Diodato, F Ceci, F Sperandi, A Ardizzoni, S Fanti
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes
2005 Musolino A; Naldi N; Michiara M; Bella MA; Zanelli P; Bortesi B; Capelletti M; Savi M; Neri TM; Ardizzoni A
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor.
2018 Mollica V, Di Nunno V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E, Ardizzoni A, Massari F
A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event
2018 Gelsomino, Francesco*; Vitale, Giovanni; Ardizzoni, Andrea
A Case of Response to Immunotherapy in a Patient With MSI Metastatic Colorectal Cancer and Autoimmune Disease in Steroid Therapy
2020 Massucci, Maria; Di Fabio, Francesca; Rojas Llimpe, Fabiola L; Ardizzoni, Andrea
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation
2008 Cascinu S; Berardi R; Salvagni S; Beretta GD; Catalano V; Pucci F; Sobrero A; Tagliaferri P; Labianca R; Scartozzi M; Crocicchio F; Mari E; Ardizzoni A
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy
2018 Gelfo V, Mazzeschi M, Grilli G, Lindzen Moshit, Santi Spartaco, D'Uva G, Győrffy B, Ardizzoni A, Yarden Y, Lauriola M.
A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)
2005 Scagliotti GV; Smit E; Bosquee L; O'Brien M; Ardizzoni A; Zatloukal P; Eberhardt W; Smid-Geirnaerdt M; de Bruin HG; Dussenne S; Legrand C; Giaccone G
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale
2022 Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Follador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
2018 Ferrarini A, Forcato C, Buson G, Tononi P, Del Monaco V, Terracciano M, Bolognesi C, Fontana F, Medoro G, Neves R, Möhlendick B, Rihawi K, Ardizzoni A, Sumanasuriya S, Flohr P, Lambros M, de Bono J, Stoecklein NH, Manaresi N
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC)
2018 Morgensztern, Daniel*; Cobo, Manuel; Ponce Aix, Santiago; Postmus, Pieter E.; Lewanski, Conrad R.; Bennouna, Jaafar; Fischer, Jürgen R.; Juan-Vidal, Oscar; Stewart, David J.; Fasola, Gianpiero; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Talbot, Denis C.; Jin Ong, Teng; Govindan, Ramaswamy
Accuracy of Fine Needle Aspiration Cytology in the Pathological Typing of Non-small Cell Lung Cancer
2011 Nizzoli R; Tiseo M; Gelsomino F; Bartolotti M; Majori M; Ferrari L; De Filippo M; Rindi G; Silini EM; Guazzi A; Ardizzoni A
ACTIVITY AND SAFETY OF DOSE-ADJUSTED INFUSIONAL CHOP CHEMOTHERAPY WITH RITUXIMAB (DA-POCH-R) IN VERY ELDERLY PATIENTS WITH POOR-PROGNOSTIC UNTREATED DIFFUSE LARGE B-CELL NON-HODGKIN'S LYMPHOMA
2010 Boggiani D; Musolino A; Panebianco M; Franciosi V; Vasini G; Salvagni S; Ardizzoni A
Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin Lymphoma
2011 Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Acute kidney injury as a possible immune-related adverse event associated with sustained complete response to BRAF and MEK inhibitors in advanced, V600E-mutated melanoma
2021 Di Federico A.; Filippini D.M.; Sperandi F.; Ardizzoni A.; Melotti B.
Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial
2022 Guido, A; Cuicchi, D; Castellucci, P; Cellini, F; Di Fabio, F; Llimpe, FLR; Strigari, L; Buwenge, M; Cilla, S; Deodato, F; Macchia, G; Galietta, E; Golfieri, R; Ardizzoni, A; Zagari, RM; Fanti, S; Poggioli, G; Fuccio, L; Morganti, AG
Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer
2019 Livi, Vanina; Ardizzoni, Andrea; Cancellieri, Alessandra; Natali, Filippo; Ferrari, Marco; Paioli, Daniela; De Biase, Dario; Capizzi, Elisa; Tallini, Giovanni; Fiorentino, Michelangelo; Trisolini, Rocco
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study
2015 Barni, Sandro; Maiello, Evaristo; Di Maio, Massimo; Ardizzoni, Andrea; Cappuzzo, Federico; Maranzano, Ernesto; Novello, Silvia; Bennati, Chiara; Ori, Alessandra; Rizzoli, Sara; Crinò, Lucio
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series | Graziani, Tiziano; Ceci, Francesco; Castellucci, Paolo; Polverari, Giulia; Lima, Giacomo Maria; L...odi, Filippo; Morganti, Alessio Giuseppe; Ardizzoni, Andrea; Schiavina, Riccardo; Fanti, Stefano | 2016-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| 11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel | Ceci, F; Castellucci, P; Graziani, T; Schiavina, R; Renzi, R; Borghesi, M; Di Tullio, P; Brunocil...la, E; Ardizzoni, A; Fanti, S | 2016-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| 18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results | G Polverari, V Ambrosini, F Gelsomino, S Diodato, F Ceci, F Sperandi, A Ardizzoni, S Fanti | 2016-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 4.02 Riassunto (Abstract) | - |
| A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes | Musolino A; Naldi N; Michiara M; Bella MA; Zanelli P; Bortesi B; Capelletti M; Savi M; Neri TM; A...rdizzoni A | 2005-01-01 | BREAST CANCER RESEARCH AND TREATMENT | - | 1.04 Replica / breve intervento (e simili) | - |
| A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. | Mollica V, Di Nunno V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E,... Ardizzoni A, Massari F | 2018-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
| A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event | Gelsomino, Francesco*; Vitale, Giovanni; Ardizzoni, Andrea | 2018-01-01 | INVESTIGATIONAL NEW DRUGS | - | 1.01 Articolo in rivista | - |
| A Case of Response to Immunotherapy in a Patient With MSI Metastatic Colorectal Cancer and Autoimmune Disease in Steroid Therapy | Massucci, Maria; Di Fabio, Francesca; Rojas Llimpe, Fabiola L; Ardizzoni, Andrea | 2020-01-01 | JOURNAL OF IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation | Cascinu S; Berardi R; Salvagni S; Beretta GD; Catalano V; Pucci F; Sobrero A; Tagliaferri P; Labi...anca R; Scartozzi M; Crocicchio F; Mari E; Ardizzoni A | 2008-01-01 | BRITISH JOURNAL OF CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy | Gelfo V, Mazzeschi M, Grilli G, Lindzen Moshit, Santi Spartaco, D'Uva G, Győrffy B, Ardizzoni A, ...Yarden Y, Lauriola M. | 2018-01-01 | CANCERS | - | 1.01 Articolo in rivista | - |
| A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956) | Scagliotti GV; Smit E; Bosquee L; O'Brien M; Ardizzoni A; Zatloukal P; Eberhardt W; Smid-Geirnaer...dt M; de Bruin HG; Dussenne S; Legrand C; Giaccone G | 2005-01-01 | LUNG CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale | Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Fo...llador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea | 2022-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products. | Ferrarini A, Forcato C, Buson G, Tononi P, Del Monaco V, Terracciano M, Bolognesi C, Fontana F, M...edoro G, Neves R, Möhlendick B, Rihawi K, Ardizzoni A, Sumanasuriya S, Flohr P, Lambros M, de Bono J, Stoecklein NH, Manaresi N | 2018-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | journal.pone.0193689.pdf |
| ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC) | Morgensztern, Daniel*; Cobo, Manuel; Ponce Aix, Santiago; Postmus, Pieter E.; Lewanski, Conrad R....; Bennouna, Jaafar; Fischer, Jürgen R.; Juan-Vidal, Oscar; Stewart, David J.; Fasola, Gianpiero; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Talbot, Denis C.; Jin Ong, Teng; Govindan, Ramaswamy | 2018-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Accuracy of Fine Needle Aspiration Cytology in the Pathological Typing of Non-small Cell Lung Cancer | Nizzoli R; Tiseo M; Gelsomino F; Bartolotti M; Majori M; Ferrari L; De Filippo M; Rindi G; Silini... EM; Guazzi A; Ardizzoni A | 2011-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| ACTIVITY AND SAFETY OF DOSE-ADJUSTED INFUSIONAL CHOP CHEMOTHERAPY WITH RITUXIMAB (DA-POCH-R) IN VERY ELDERLY PATIENTS WITH POOR-PROGNOSTIC UNTREATED DIFFUSE LARGE B-CELL NON-HODGKIN'S LYMPHOMA | Boggiani D; Musolino A; Panebianco M; Franciosi V; Vasini G; Salvagni S; Ardizzoni A | 2010-01-01 | ANNALS OF ONCOLOGY | - | 1.06 Abstract in rivista | - |
| Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin Lymphoma | Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A | 2011-01-01 | CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Acute kidney injury as a possible immune-related adverse event associated with sustained complete response to BRAF and MEK inhibitors in advanced, V600E-mutated melanoma | Di Federico A.; Filippini D.M.; Sperandi F.; Ardizzoni A.; Melotti B. | 2021-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial | Guido, A; Cuicchi, D; Castellucci, P; Cellini, F; Di Fabio, F; Llimpe, FLR; Strigari, L; Buwenge,... M; Cilla, S; Deodato, F; Macchia, G; Galietta, E; Golfieri, R; Ardizzoni, A; Zagari, RM; Fanti, S; Poggioli, G; Fuccio, L; Morganti, AG | 2022-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer | Livi, Vanina; Ardizzoni, Andrea; Cancellieri, Alessandra; Natali, Filippo; Ferrari, Marco; Paioli..., Daniela; De Biase, Dario; Capizzi, Elisa; Tallini, Giovanni; Fiorentino, Michelangelo; Trisolini, Rocco | 2019-01-01 | THE CLINICAL RESPIRATORY JOURNAL | - | 1.01 Articolo in rivista | - |
| Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study | Barni, Sandro; Maiello, Evaristo; Di Maio, Massimo; Ardizzoni, Andrea; Cappuzzo, Federico; Maranz...ano, Ernesto; Novello, Silvia; Bennati, Chiara; Ori, Alessandra; Rizzoli, Sara; Crinò, Lucio | 2015-01-01 | LUNG CANCER | - | 1.01 Articolo in rivista | - |